Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Jui Yi Chen"'
Autor:
Jia-Yuh Sheu, Li-Yang Chang, Jui-Yi Chen, Heng-Chih Pan, Chi-Shin Tseng, Jeff S. Chueh, Vin-Cent Wu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Sodium-glucose cotransporter 2 inhibitors (SGLT-2i) have demonstrated efficacy in reducing cardiovascular events and potentially improving kidney function in diabetic patients. This investigation analyzes the TriNetX database to assess the e
Externí odkaz:
https://doaj.org/article/0664842451394b78a95a49ac5f1a6931
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-14 (2024)
Abstract Background Sodium-glucose cotransporter 2 inhibitors (SGLT-2is) have demonstrated associations with lowering cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, the impact of SGLT-2is on individuals at dialysis
Externí odkaz:
https://doaj.org/article/91fe516990dd466b9cacda6ba383245c
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) have demonstrated efficacy in improving mortality and cardiovascular (CV) outcomes. However, the impact of GLP-1RAs therapy on cardiorenal outcomes of diabetic patients at the c
Externí odkaz:
https://doaj.org/article/c13e2393f5194c9db441d7d387d78f58
Autor:
Kun-Mo Lin, Ching-Chun Su, Jui-Yi Chen, Szu-Yu Pan, Min-Hsiang Chuang, Cheng-Jui Lin, Chih-Jen Wu, Heng-Chih Pan, Vin-Cent Wu
Publikováno v:
Kidney Research and Clinical Practice, Vol 43, Iss 4, Pp 393-405 (2024)
Traditional acute kidney injury (AKI) classifications, which are centered around semi-anatomical lines, can no longer capture the complexity of AKI. By employing strategies to identify predictive and prognostic enrichment targets, experts could gain
Externí odkaz:
https://doaj.org/article/c59520ca3a5149698c1baacc5ca8d73e
Autor:
Heng-Chih Pan, Jui-Yi Chen, Hsing-Yu Chen, Fang-Yu Yeh, Chiao-Yin Sun, Thomas Tao-Min Huang, Vin-Cent Wu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Previous studies have explored the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in reducing cardiovascular events in type 2 diabetes. Here we show that GLP-1 RAs are associated with lower risks of mortality, major cardiov
Externí odkaz:
https://doaj.org/article/af1e9e6c27d6458baada297ce5415143
Autor:
Ting-Wei Kao, Jui-Yi Chen, Jung-Hua Liu, Wen-Hsin Tseng, Chih-Chia Hsieh, Vin-Cent Wu, Yen-Hung Lin, Zheng-Wei Chen
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 15 (2024)
Background: The aldosterone-to-renin ratio (ARR) is commonly used for screening primary aldosteronism (PA) in patients with difficult-to-control hypertension. Various thresholds have been proposed for the confirmatory tests, leading to inconsistency
Externí odkaz:
https://doaj.org/article/3603d01f29834b78912b5cbf3915a98d
Autor:
Min-Hsiang Chuang, Yu-Shuo Tang, Jui-Yi Chen, Heng-Chih Pan, Hung-Wei Liao, Wen-Kai Chu, Chung-Yi Cheng, Vin-Cent Wu, Michael Heung
Publikováno v:
Diabetes & Metabolism Journal, Vol 48, Iss 2, Pp 242-252 (2024)
Background The initiation of sodium-glucose cotransporter-2 inhibitors (SGLT2i) typically leads to a reversible initial dip in estimated glomerular filtration rate (eGFR). The implications of this phenomenon on clinical outcomes are not well-defined.
Externí odkaz:
https://doaj.org/article/a917943dba6a4adc88793a7edb56cc81
Autor:
Chun-Chi Yang, Jui-Yi Chen, Hsuan-Yuan Chang, Ming-Jen Sheu, I-Che Feng, Su-Hung Wang, Hsing-Tao Kuo
Publikováno v:
Case Reports in Gastroenterology, Vol 18, Iss 1, Pp 136-143 (2024)
Introduction: Syphilis, an ancient sexually transmitted disease, is recognized as a systemic infection disease manifesting with diverse symptoms and variations. Secondary syphilis characterized by systemic symptoms resulted from hematogenous and lymp
Externí odkaz:
https://doaj.org/article/1b7b5cba8e964fb8a26e71f891b41168
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/e542fc5838964b478f9b9fc1e9fe3095
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 56, Iss 6, Pp 1158-1168 (2023)
Background: Primary Aldosteronism (PA) is a common subtype of hypertension that increases the risk of adverse cardiovascular and kidney events. The impact of COVID-19 on patients with PA is not well understood.This study aimed to investigate the impa
Externí odkaz:
https://doaj.org/article/9156745a199f4f6b89a6977b7dc28df0